ArticleCancers2020

Fatty Acid Synthase Inhibitor G28 Shows Anticancer Activity in EGFR Tyrosine Kinase Inhibitor Resistant Lung Adenocarcinoma Models.

Emma Polonio-Alcalá et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.